Filing Flows › Cronos Group (CRON) › Q3 2026 › vs Q3 2025
Cronos Group (CRON) Q3 2026 vs Q3 2025 (year over year)
Cronos Group's revenue rose $35.1M (+72%) from $48.8M in Q3 2025 to $83.9M in Q3 2026. The biggest changes: Cannabis flower +$21.6M (+82%); Other revenues +$8.0M (+64%); Cannabis extracts +$5.5M (+55%). Gross margin 38.5% against 37.5% (+0.9 pts).
Cronos Group, Q3 2026: revenue $83.9M (+72% year over year), operating margin 10.8%, net earnings $13.8M, operating cash flow $34.3M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 38.5% | 37.5% | +0.9 pts |
| Operating margin | 10.8% | -1.0% | +11.8 pts |
| Net margin | 16.5% | 53.2% | -36.7 pts |
| Free cash flow margin | 29.1% | 18.1% | +11.0 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Cannabis flower | $48.0M | $26.4M | $21.6M | +82% |
| Cannabis extracts | $15.5M | $10.0M | $5.5M | +55% |
| Other revenues | $20.5M | $12.5M | $8.0M | +64% |
| Revenue | $83.9M | $48.8M | $35.1M | +72% |
| Gross profit | $32.3M | $18.3M | $14.0M | +76% |
| Cost of revenue | $51.6M | $30.5M | $21.1M | +69% |
| Other income, net | $9.7M | $27.5M | −$17.8M | -65% |
| Operating profit | $9.0M | −$503K | $9.5M | — |
| Operating expenses | $23.3M | $18.8M | $4.4M | +23% |
| Pre-tax earnings | $18.7M | $27.0M | −$8.3M | -31% |
| Research & development | $1.3M | $1.3M | −$9K | -0.7% |
| Sales & marketing | $7.1M | $5.3M | $1.8M | +35% |
| General & admin | $12.0M | $9.3M | $2.7M | +30% |
| Other operating costs | $2.8M | $2.9M | −$151K | -5% |
| Net earnings | $13.8M | $26.0M | −$12.2M | -47% |
| Minority interests | $4.0M | $2.4M | $1.7M | +70% |
| Income tax | $898K | −$1.3M | $2.2M | — |
| Depreciation & amortization | $4.7M | $3.5M | $1.2M | +33% |
| Share-based compensation | $2.3M | $2.3M | −$23K | -1% |
| Working capital & other | $13.5M | −$18.5M | $32.0M | — |
| Operating cash flow | $34.3M | $13.3M | $21.0M | +158% |
| Free cash flow (OCF − capex) | $24.4M | $8.8M | $15.6M | +176% |
| Capital expenditures | $9.9M | $4.5M | $5.5M | +122% |
Questions
How much did Cronos Group's revenue grow year over year in Q3 2026?
Cronos Group's revenue rose $35.1M (+72%) from $48.8M in Q3 2025 to $83.9M in Q3 2026.
What drove Cronos Group's revenue change in Q3 2026?
Cannabis flower +$21.6M (+82%); Other revenues +$8.0M (+64%); Cannabis extracts +$5.5M (+55%).